Linagliptin (GSK2118436)
Product Specifications
CAS Number
668270-12-0
Synonyms
BI-1356
Target
Ferroptosis
Applications
Apoptosis
Smiles
CC#CCN1C2=C (N=C1N3CCCC (C3) N) N (C (=O) N (C2=O) CC4=NC5=CC=CC=C5C (=N4) C) C
Molecular Formula
C25H28N8O2
Additionnal Information
Linagliptin (GSK2118436) is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM and exhibits a 10,000-fold higher selectivity for DPP-4 than for other dipeptidyl peptidases such as DPP-2, DPP-8, and DPP-9. Linagliptin activates glomerular autophagy in a model of type 2 diabetes. DPP4 mediates ferroptosis in TP53-deficient CRC cells.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040008-100 1x 100 µL
MAGE A1 (MA454), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470218-500 1x 500 µL
CD100 (Semaphorin-4D) (A8), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881481-500 1x 500 µL
S100A4 (Marker of Tumor Metastasis) (S100A4/1481), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880960-100 1x 100 µL
MUC1 / EMA / CD227 (Epithelial Marker) (rMUC1/960), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details